To evaluate the results of revascularization of stenotic iliac stents using drug-eluting balloons (DEBs).
Material and Methods
Seventy-four patients with various levels of iliac stent restenosis were enrolled to study. All restenotic stents were treated using paclitaxel-coated balloons.
Results
Through a follow-up median period of 24 months (4–24 months), there were no in-stent re-restenosis in 55 patients (74.3%) and there was one in class 1 (1.4%), four in class 2 (5.4%), and fourteen in class 3 (18.9%).
Conclusion
We conclude that; DEBs can be used for restenotic iliac artery stents for some Type C and D lesions, in addition to Types A and B with satisfacting results.
SapovalMRChatellierGLongAL, et al.Self-expandable stents for the treatment of iliac artery obstructive lesions: long-term success and prognostic factors. AJR Am J Roentgenol1996; 166(5): 1173–1179.
2.
SixtSAlawiedAKRastanA, et al.Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification: a single-center experience. J Endovasc Ther2008; 15(4): 408–416.
3.
CarnevaleFCDe BlasMMerinoS, et al.Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol2004; 27: 447–452.
4.
GandiniRFabianoSChiocchiM, et al.Percutaneous treatment in iliac artery occlusion: long-term results. Cardiovasc Intervent Radiol. 2008; 31: 1069–1076.
5.
TimaranCHPraultTLStevensSL, et al.Iliac artery stenting versus surgical reconstruction for TASC (Trans-Atlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg2003; 38: 272–278.
6.
YilmazSSindelTLuleciE. Subintimal versus intraluminal recanalization of chronic iliac occlusions. J Endovasc Ther2004; 11: 107–118.
7.
KudoTChandraFAAhnSSLong-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg2005; 42: 466–475.
8.
HoffmannRMintzGSDussaillantGR, et al.Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation1996; 94: 1247–1254.
9.
JohnstonKWRaeMHogg-JohnstonSA, et al.5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg1987; 206: 403–413.
10.
TroisiNErcoliniLPerettiE. Drug-eluting balloons to treat Iliac in-stent restenosis. Ann Vasc Surg2015; 29: 1315. DOI: 10.1016/j.avsg.2015.02.021.
11.
MüllerALangwieserNBradaricC, et al.Endovascular treatment for steno-occlusive iliac artery disease: safety and long-term outcome. Angiology2018; 69(4): 308–315.
12.
CutlipDEChauhanMSBaimDS, et al.Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol2002; 40(12): 2082–2089.
13.
KuntzRESafianRDCarrozaJP, et al.The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation1992; 86(6): 1827–1835.
14.
KuntzREGibsonCMNobuyoshiM, et al.Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol1993; 21(1): 15–25.
15.
LevilleCDKashyapVSClairDG, et al.Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg2006; 43: 32–39.
16.
AliATModrallJGLopezJ, et al.Emerging role of endovascular grafts in complex aortoiliac occlusive disease. J Vasc Surg2003; 38: 486–491.
17.
DaviesMGBismuthJSaadWE, et al.Outcomes of reintervention for recurrent disease after percutaneous iliac angioplasty and stenting. J Endovasc Ther2011; 18: 169–180.
18.
KropmanRHBemelmanMVosJA. Long-term results of percutaneous transluminal angioplasty for symptomatic iliac in-stent stenosis. Eur J Vasc Endovasc Surg2006; 32: 634–638.
